SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

WQG WCM Global Growth Limited

Financial Services · Asset Management · website
$2.04
52wk 1.61 – 2.26
Overall
81.8
Value
84.8
Growth
70.9
Health
100.0
Quality
91.1
Momentum
72.4
Dividend
60.9
Price
About WCM Global Growth Limited

Contango Global Growth Limited is an equity mutual fund launched by Contango International Management Pty Ltd. The fund is managed by WCM Investment Management. It invests in public equity markets of emerging countries across the globe. The fund seeks to invest in stocks of companies operating across diversified sectors. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund seeks to benchmark the performance of its portfolio against the MSCI All Country World Index ex-Australia. Contango Global Growth Limited was formed on June 23, 2017 and is domiciled in Australia.

Price analytics

Returns

1 day -1.9%
1 week -5.1%
1 month -1.0%
3 months 3.6%
6 months 17.2%
1 year 5.2%
3 years 69.3%

Risk

Volatility (1y ann.) 25.2%
Beta vs ASX 200 0.58
Sharpe (1y) 0.17
VaR 95% (1-day) -2.6%
Max drawdown (1y) -22.2%
Off 1-year high -6.8%

Technicals

RSI(14) 57
vs 50DMA -2.0%
vs 200DMA 6.0%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 84.8
Trailing P/E
100
Forward P/E
—
PEG ratio
—
EV / EBITDA
—
Price / Book
96
Price / Sales
48
Growth 70.9
Revenue growth (1y)
13
Revenue CAGR (3y)
100
EPS growth (1y)
100
EPS CAGR (3y)
—
Financial Health 100.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
—
Quality (Profitability & Cash Flow) 91.1
Return on equity
71
Return on assets
100
Operating margin
100
Net margin
100
Cash conversion (OCF / net income)
—
Dividend / Income 60.9
Dividend yield (%)
70
Payout ratio
100
FCF dividend cover
0
Momentum 72.4
6-month return vs ASX 200
100
Price vs 200-day average
70
Price vs 50-day average
40
Position in 52-week range
66

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$570.95M
P/E (trailing)
7.29
P/E (forward)
—
EPS (trailing)
0.28
Dividend yield
4.3%
Payout ratio
30.6%
Beta
0.53
EV / EBITDA
—
Price / Book
1.05
ROE
14.1%
Operating margin
94.4%
Net margin
65.3%
Total cash
$601.21M
Total debt
$0
Current ratio
31.05
Debt / Equity
—
Free cash flow
$61.95M
Avg volume
232,964
Latest annual results (FY ending 30 Jun 2026)
  • Revenue$101.75M
  • Gross profit—
  • Operating income—
  • Net income$66.72M
  • Diluted EPS—
  • Free cash flow-$47.52M
  • Net debt-$34.20M
Sector peers (Financial Services)
TickerMkt cap P/EScore
CBA $253.20B 23.3 38.2
NAB $117.86B 19.2 55.3
WBC $117.20B 16.9 45.3
ANZ $112.52B 19.0 56.2
MQG $93.62B 25.3 57.4
QBE $35.57B 11.6 80.1
CPU $23.13B 26.0 69.3
SUN $19.45B 19.3 52.7